Predicting stroke risk after transient ischemic attack using scoring systems
The Role of TIA Scores and NIHSS Score in Predicting Early and Late Ischemic Stroke Risk in Patients Presenting With Transient Ischemic Attack to the Emergency Department
This study is trying to see which scoring systems can best predict the risk of having a stroke within 30 days for people who have had a transient ischemic attack (TIA).
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Saglik Bilimleri Universitesi Academic / other |
| Locations | 1 site (Ankara, Yenimahalle) |
| Trial ID | NCT06515392 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of various scoring systems, including ABCD2, ABCD3-I, Canadian TIA Score, and NIHSS Score, in predicting the likelihood of ischemic stroke within 30 days for patients presenting with transient ischemic attack (TIA) at the emergency department. Researchers will collect data on approximately 300 patients diagnosed with TIA, assessing their health status and any recurrent strokes or TIAs after 30 days. The study will not involve any treatment interventions but will focus on gathering and analyzing patient data over a one-year period.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and above who have been diagnosed with a transient ischemic attack.
Not a fit: Patients with hemorrhagic stroke or those who are unwilling to participate in the study may not receive any benefit.
Why it matters
Potential benefit: If successful, this study could enhance the ability to predict stroke risk in TIA patients, potentially leading to better patient management and outcomes.
How similar studies have performed: Other studies have shown promise in using scoring systems for stroke risk prediction, indicating that this approach is supported by existing research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients presenting to the emergency department and diagnosed with TIA Patients diagnosed with ischemic stroke who did not receive thrombolytic therapy based on NIHSS score Patients aged 18 and above Patients who consented by signing the informed consent form Exclusion Criteria: Patients diagnosed with hemorrhagic stroke Patients unwilling to participate in the study Patients with a history of trauma Patients unable to receive thrombolytic therapy for any reason (trauma, malignancy, etc.) Patients under the age of 18 Patients transferred from another hospital Patients who experienced cardiac arrest Patients who died for any reason other than ischemic stroke within 30 days Patients wishing to withdraw from the study at any time during the study period
Where this trial is running
Ankara, Yenimahalle
- Etlik City Hospital — Ankara, Yenimahalle, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: gulsen akcay, ass. prof.
- Email: gulakcay@yahoo.com.tr
- Phone: +905052874949
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.